Previous Article in Journal
Advances and Challenges in Scoring Functions for RNA–Protein Complex Structure Prediction
Previous Article in Special Issue
Assessment of Antimicrobial and Cytotoxic Activities of Liposomes Loaded with Curcumin and Lippia origanoides Essential Oil
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Identification of Sinapic Acid Derivatives from Petit Vert Leaves and Their Effects on Glucose Uptake in C2C12 Murine Myoblasts

1
Center for Pharma-Food Research (CPFR), Graduate School of Pharmaceutical Sciences, Shizuoka 422-8526, Japan
2
School of Food Nutritional Sciences, University of Shizuoka, Shizuoka 422-8526, Japan
3
Kagawa School of Pharmaceutical Sciences, Tokushima Bunri University, Sanuki 769-2193, Japan
4
Shizuoka Shin-Food Development Corp., Shizuoka 422-8064, Japan
*
Author to whom correspondence should be addressed.
Biomolecules 2024, 14(10), 1246; https://doi.org/10.3390/biom14101246
Submission received: 21 August 2024 / Revised: 18 September 2024 / Accepted: 27 September 2024 / Published: 1 October 2024

Abstract

:
Petit vert (scientific name: Brassica oleracea var. gemmifera DC. × Brassica oleracea var. acephala DC.) is a new variety of vegetable created by crossbreeding kale and brussel sprouts (Brassica oleracea species). The present study aimed to identify biologically active compounds in extracts of the outer leaves of Petit vert by purification and to examine their biological activities. The dried and powdered outer leaves of Petit vert were extracted, fractionated, and purified to isolate active compounds. Mass spectrometry (MS) was used to identify the compounds, and nuclear magnetic resonance (NMR) spectroscopy was performed to elucidate their structures. The compounds isolated from Petit vert leaves were glycosides that contained kaempferol, quercetin (flavonol), or sinapic acid (phenylpropanoid). Glucose uptake in cultured C2C12 murine myoblasts in the absence of insulin was significantly increased by these compounds, kaempferol, sinapic acid, and ferulic acid, while uptake in the presence of insulin was also significantly increased by compounds 3 and 4, kaempferol, and sinapic acid. The effect was not necessarily concentration-dependent, and some agents decreased the glucose uptake at higher concentrations. The present study reports for the first time the isolation of five compounds containing sinapic acid from the outer leaves of Petit vert and their stimulation of glucose uptake in cultured C2C12 murine myoblasts. The results obtained herein suggest the potential of these compounds to effectively attenuate hyperglycemia and maintain muscle strength by promoting glucose metabolism in muscle cells.

1. Introduction

Polyphenols are phenolic compounds that are present in plants and play a role in defense against harmful oxidative damage. Among polyphenol compounds, hydroxycinnamic acid and its derivatives are well-known chemical groups that have important biological functions, such as anti-inflammatory and antioxidant activities [1]. The beneficial effects of these compounds as preventive or therapeutic agents have previously been shown in various diseases, such as inflammatory damage and cancer [2,3]. Among hydroxycinnamic acids, sinapic acid [(2E)-3-(4-hydroxy-3,5-dimethoxyphenyl)prop-2-enoic acid], a natural herb phenolic acid compound, is present in herbs, such as oranges, grapefruits, cranberries, rapeseeds, and mustard seeds [4]. Sinapic acid was previously shown to prevent scopolamine-induced cognitive impairments in memory in a rat model [5,6]. It also exhibited anti-inflammatory activity in carbon tetrachloride-induced acute liver damage and significantly decreased proinflammatory cytokine levels [7,8]. Furthermore, sinapic acid attenuated and prevented neuroinflammation, cholinergic deficits, and oxidative stress [9].
Petit vert (scientific name: Brassica oleracea var. gemmifera DC. × Brassica oleracea var. acephala DC.) (Figure 1) is a new variety of vegetable created by crossbreeding kale and brussel sprouts (Brassica oleracea species). Its anti-obesity effects were previously demonstrated in mice fed a high-fat diet containing 5% freeze-dried Petit vert [10]; however, the composition and identity of the active compounds present in Petit vert remain unclear. Since only the leafy side shoots of Petit vert are harvested, the outer leaves, which are of high nutritional value, are typically discarded because they contain rough fibers. Therefore, the present study aimed to identify biologically active compounds in extracts of the outer leaves of Petit vert by purification and to examine their biological activities. Dried and powdered outer leaves of Petit vert were extracted, fractionated, and purified to isolate active compounds. Nuclear magnetic resonance (NMR) and mass (MS) spectrometry were performed to elucidate the structures of five compounds. The compounds isolated from Petit vert leaves were glycosides containing either kaempferol, quercetin (flavonol), or sinapinic acid (phenylpropanoid).

2. Materials and Methods

2.1. Materials

Petit vert (B. oleracea var. gemmifera DC. × B. oleracea var. acephala DC.) is an agricultural product. It was cultivated by seedlings and purchased from Masuda Seed Farm Col. Ltd. (Shizuoka, Japan). Test compounds (15) were isolated from Petit vert. Quercetin (6), kaempferol (7), sinapic acid (8), ferulic acid (9), and caffeic acid (10) were purchased from Merck KGaA (Darmstadt, Germany). Penicillin-streptomycin solution, a 0.25% trypsin/EDTA solution, cell count reagent SF (WST-8), and Dulbecco’s modified Eagle’s medium (DMEM) were purchased from Nacalai Tesque Inc. (Kyoto, Japan). Gelatin, type A and Gibco™ Insulin, human recombinant, zinc solution were purchased from MP Biomedicals (Irvine, CA, USA) and Thermo Fisher Scientific (Waltham, MA, USA), respectively. Fetal bovine serum (FBS) was obtained from Nichirei Biosciences Inc. (Tokyo, Japan). All other chemicals used were of the highest purity commercially available. All solvents were of high-performance liquid chromatography (HPLC) grade, and water was of Milli-Q quality.

2.2. Extraction and Isolation

Petit vert is usually harvested from February to March in Japan. The outer leaves were harvested at the same time. Petit vert leaves were dried at 55 °C for 7 h and ground to a powder in a domestic blender. Polyphenols were extracted from 400 g of dried Petit vert leaf powder with 6 L of methanol under reflux conditions (around 70 °C) for 2 h before filtering. The filtrate was evaporated, and the extract was suspended in 1.3 L of 90% aqueous methanol. The suspension was washed three times with 1.3 L of n-hexane, and the extract was evaporated and suspended in 1.3 L of distilled water. The extract was washed three times with 1.3 L of ethyl acetate. The extract was again evaporated and then dissolved in 1 L of distilled water. The extract was charged on a porous polymer gel (DIAION HP-20, Mitsubishi Chemical Co., Chiyoda City, Japan) column and eluted with 3 L of distilled water, 3 L of 50% aqueous methanol, and 3 L of methanol. Extracts were evaporated to obtain the phenolic extract (103.7, 8.4, and 2.4 g, respectively). The 50% aqueous methanol eluate (7.6 g) was charged on a TOYOPEARL HW-40 column (TOSOH, Tokyo, Japan) and then eluted with 10% aqueous ethanol and 50% aqueous ethanol to obtain eight fractions (fractions A–H). Fraction C (705 mg) was purified by preparative HPLC (Inertsil ODS-3, i.d., 30 × 250 mm, PU714Mx2, GL Sciences Inc., Tokyo, Japan), and compounds 25 (2; 41.6 mg, 3; 34.8 mg, 4; 90.5 mg, 5; 53.8 mg), which were of sufficient purity and quantity for complete chemical characterization, were isolated. The MeOH eluate (2.4 g) was charged on a TOYOPEARL HW-40 column (TOSOH, Tokyo, Japan) and then eluted with 50% aqueous ethanol and 85% aqueous ethanol to obtain six fractions (fractions A–F). Fraction B (785 mg) was purified by preparative HPLC (Inertsil ODS-3, i.d., 30 × 250 mm, GL Sciences Inc., Tokyo, Japan), and compound 1 (33.4 mg) was isolated.

2.3. Identification of Phenolic Compounds by HPLC

To isolate flavonoids and hydroxycinnamic acid derivatives, HPLC (CBM-20A, Shimadzu, Japan) consisting of a degasser, quaternary pump, thermostat, a UV detector set at 330 nm, and an injection valve was used. Extracts were analyzed on a Cosmosil 2.5 Cholester column (100 × 3 mm, 2.5 µm; Nacalai Tesque, Inc.) at a temperature of 40 °C using a gradient of (A) 0.1% trifluoroacetic acid in water and (B) acetonitrile. The following gradient with a flow rate of 0.75 mL/min was used: 6–11% B (0–20 min), 11–27% B (20–36 min), and 27% B isocratic (36–45 min).

2.4. Structural Elucidation of Phenolic Compounds by NMR and MS

The structures of compounds 15 were identified by NMR spectroscopy. 1H and 13C NMR spectra were analyzed on a JNM ECA-500 spectrometer using the Delta/NMR software system (JEOL, Tokyo, Japan) (500 MHz for 1H and 125 MHz for 13C) or a Bruker Avance 700 spectrometer using the MestReNova software system (Bruker, Billerica, MA, USA) (700 MHz for 1H and 175 MHz for 13C) in CD3OD or DMSO-d6. Chemical shifts are given in δ (ppm) using tetramethylsilane (TMS) as an internal standard. The 2D-NMR spectra were carried out with the same spectrometer. Inverse-detected heteronuclear correlations were measured using HSQC (optimized 1JC-H = 140 Hz) and HMBC (optimized 3JC-H = 8 Hz) pulse sequences with a pulse field gradient. The ROESY spectrum was recorded with a mixing time of 300 ms. High resolution (HR) electrospray ionization (ESI) MS data on compounds 25 were obtained on a Waters/Micromass Q-TOF micro MS using MassLynx software system (Waters, MA, USA) in the negative ion mode.

2.5. Cell Culture

C2C12 mouse myoblast cells were purchased from the American Type Culture Collection (Manassas, VA, USA). C2C12 cells form a myoblast cell line, which is a subclone (produced by H. Blau et al.) of the mouse myoblast cell established by D. Yaffe and O. Saxel. The study was conducted according to the guidelines of the Declaration of Helsinki (2013). The experiment was approved by the Committee for Research at the University of Shizuoka Research Ethical Board approved on 2 June 2019. Cells were cultured in DMEM with 25 mM glucose, 10% FBS, and 1% antibiotic solution containing penicillin and streptomycin at 37 °C in a humidified atmosphere of 5% CO2–95% air. Cells were plated in a 96-well microplate (100 µL well−1) at a density of 4 × 104 cells well−1. Confluent myoblasts were differentiated to myotubes by a decrease in serum concentrations to 0.1% and the addition of 5 µg/mL insulin. Myotubes formed after 4 days of incubation and were used in subsequent experiments.

2.6. Cell Viability Assay

Cell viability assays were performed using the cell count reagent SF (WST-8). The WST-8 reagent solution (10 µL) was added to each well of a 96-well microplate containing 100 µL of a cell suspension in culture medium and the test compounds (110) at various concentrations (1, 10, and 100 µM). Plates were incubated at 37 °C for 24 h. Control wells (0.1% DMSO) containing the same volume of complete culture medium were included in each assay. After being cultured for 24 h, absorbance was measured at 450 nm using a microplate reader (Varioskan Flash, Thermo Fisher Scientific Waltham, MA, USA). Measurements were performed with triplicate dishes of three different experiments.

2.7. Assay of Glucose Uptake in C2C12 Mouse Myoblast Cells

The glucose uptake rate was measured using the Glucose Uptake-GloTM Assay kit (Promega Corporation, Madison, WI, USA) according to the manufacturer’s instructions. This assay measures glucose uptake in cells based on the detection of 2-deoxyglucose-6-phosphate. Test compounds (110) were added at various concentrations (1, 10, and 100 µM) to each well of a 96-well microplate containing cells in culture medium, and the plate was incubated at 37 °C for 24 h. Control wells (0.1% DMSO) containing the same volume of a complete culture medium were included in each assay. Before the assay on glucose uptake, cells were placed in a serum-free medium for 18 h. C2C12 mouse myoblast cells were then cultured in DMEM with 25 mM glucose and 10% FBS in the presence or absence of insulin and the test substances (1, 10, and 100 μM) for 1 h. Fluorescence intensity was measured using a fluorescence spectrofluorometer (Varioskan Flash, Thermo Fisher Scientific Waltham, MA, USA) and was used to calculate glucose in the cells.

2.8. Statistical Analysis

Data were statistically analyzed using Student’s t-test after an analysis of variance. Results are shown as the mean ± S.E. unless otherwise stated.

3. Results

3.1. Structural Elucidation of Phenolic Compounds by NMR

13C and 1H NMR spectroscopic data on compound 1 showed two characteristic anomeric proton and carbon signals for β-D-glucopyranosyl groups at δC 91.9, 103.1, δH 5.77 (1H, d, J = 8.0 Hz), 4.20 (1H, d, J = 8.0 Hz) and two trans-sinapoyl groups at δC 164.9, 148.0 × 2, 145.8, 138.4, 124.3, 113.5, 106.3 × 2, 56.1 × 2, δH 7.55 (1H, d, J = 16.0 Hz), 6.99 (1H, s) ×2, 6.49 (1H, d, J = 16.0 Hz), 3.77 (3H, s) × 2 and δC 165.6, 148.0 × 2, 147.3, 138.9, 124.0, 114.6, 106.6 × 2, 56.1 × 2, δH 7.53 (1H, d, J = 16.0 Hz), 6.96 (1H, s) × 2, 6.44 (1H, d, J = 16.0 Hz), and 3.78 (3H, s) × 2. Therefore, compound 1 consisted of two β-D-glucopyranosyl and two trans-sinapoyl groups. Consistent with NMR spectroscopic data on compound 1 in the literature, compound 1 was assigned as 1,2-disinapoylgentiobiose [11].
The molecular formula for new compound 2, C50H60O31, was established based on HR-ESI-MS [m/z: 1155.3058 [M-H]]. The aglycone of compound 2 was identified as quercetin based on observations of fifteen carbon signals, including twelve aromatic carbon signals (δC 164.1, 162.2, 157.3, 149.8, 145.9, 123.3 × 2, 117.2, 116.1, 107.5, 100.6, and 95.4), two olefin carbons (δC 157.5 and 135.0), and one carbonyl carbon (δC 179.1), and AM-type aromatic protons [δH 6.37 (1H, d, J = 2.0 Hz) and 6.34 (1H, d, J = 2.0 Hz)] derived from the A-ring and AMX-type aromatic proton signals [δH 7.50 (1H, d, J = 2.0 Hz) 7.45 (1H, dd, J = 8.5, 2.0 Hz) and 6.88 (1H, d, J = 8.5 Hz)] derived from the B-ring in 13C and 1H NMR spectroscopic data. Moreover, in the 13C and 1H NMR spectra of compound 2, four anomeric carbon and proton signals of β-D-glucopyranosyl groups were observed at δC 96.9, 98.4, 101.2, 104.5, and δH 6.18 (1H, d, J = 8.0 Hz), 5.24 (1H, d, J = 8.0 Hz), 5.13 (1H, d, J = 8.0 Hz), and 4.48 (1H, d, J = 8.0 Hz) together with signals due to one trans-sinapoyl group [δC 168.6, 148.7 × 2, 146.6, 138.7, 125.9, 115.9, 105.5 × 2, 56.2 × 2 and δH 7.30 (1H, d, J = 16.0 Hz), 6.23 (1H, s) × 2, 6.09 (1H, d, J = 16.0 Hz), 3.59 (3H, s)×2]. These components of compound 2 were confirmed by alkaline and acid hydrolysis. 13C and 1H NMR signals were assigned (Table 1 and Table 2) based on the results of two-dimensional (2D)-NMR [1H-1H correlation spectroscopy (COSY), 1H-detected heteronuclear single-quantum correlation spectroscopy (HSQC), and 1H-detected hetero-nuclear multiple-bond connectivity (HMBC)] measurements. In addition, the HMBC experiment provided information on sugar and ester linkages. 3JCOCHs were observed between C-3 of the aglycone (δC 135.0) and H-1 of β-D-glucopyranose (δH 6.18), C-2 of β-D-glucopyranose (δc 82.0), H-1′ of β-D-glucopyranose (δH 5.24), C-7 of the aglycone (δC 164.1), H-1″ of β-D-glucopyranose (δH 5.13), C-4″ of β-D-glucopyranose (δc 80.1), and H-1‴ of β-D-glucopyranose (δH 4.48). These sugar linkages were also indicated by the results of a rotating frame nuclear Overhauser effect correlation spectroscopy (ROESY) experiment (Figure 2). Moreover, the acylation shift of the H-2′ signal of β-D-glucopyranose (δH 4.93) suggested that the sinapoyl group was attached at C-2′ of β-D-glucopyranose, which was supported by the results of the HMBC experiment. Therefore, compound 2 was identified as quercetin 3-O-β-D-[2-O-3,5-dimethoxy-4-hydroxy-(E)-cinnamoyl]-glucopyranosyl-(1→2)-β-D-glucopyranoside-7-O-β-D-glucopyranosyl-(1→4)-β-D-glucopyranoside.
Based on HR-ESI-MS, compound 3 had the molecular formula C44H50O26, which was smaller by one glucosyl unit than that of compound 2 [m/z: 993.2518 [M-H]]. 13C- and 1H-NMR spectroscopic data on the aglycone and 3-O-side chain were consistent with those of compound 2. However, since the signals of only one β-D-glucopyranosyl group were observed in the 7-O-side chain, this chain consisted of one β-D-glucopyranose. Therefore, compound 3 was identified as quercetin 3-O-β-D-[2-O-3,5-dimethoxy-4-hydroxy-(E)-cinnamoyl]-glucopyranosyl-(1→2)-β-D-glucopyranoside-7-O-β-D-glucopyranoside [12,13].
Compounds 4 and 5 were assigned the molecular formulae C50H60O30 and C44H50O25, respectively, by HR-ESI-MS [compound 4: m/z: 1139.3077 [M-H], compound 5: m/z: 977.2565 [M-H]]. The aglycones of compounds 4 and 5 were identified as kaempferol because AA′XX′-type aromatic proton signals derived from the B-ring were observed in each 1H NMR spectrum [δH 7.89 (1H, d, J = 8.5 Hz) × 2, 6.90 (1H, d, J = 8.5 Hz) × 2]. NMR spectroscopic data, due to the sugar and ester moieties of compounds 4 and 5, were consistent with those of compounds 2 and 3, respectively. Therefore, the structures of compounds 4 and 5 were elucidated, as shown in Figure 3 [12,13,14,15] (Chart S1). In addition to the sinapoyl group containing the compounds reported herein, some flavonoid glycosides containing p-coumaroyl, caffeoyl, or feruloyl groups in their molecules were obtained. Since Petit vert is an improved variety of B. oleracea, similarities in its composition with that of B. oleracea were observed [12,14,15]. The HPLC analysis of Petit vert leaves and side shoots demonstrated that compounds 25 with flavonols were more abundant in the leaves than in the side shoots. On the other hand, compound 1, which contained only sinapic acid, was more abundant in the side shoots (Figure 4).

3.2. Effects on Glucose Uptake in Cultured C2C12 Murine Myoblasts

We examined the effects of the following 10 compounds on glucose uptake in cultured C2C12 murine myoblasts: the 5 compounds isolated from the outer leaves of Petit vert (compounds 15), quercetin, kaempferol (aglycone), and related acyl groups, including sinapic acid, ferulic acid, and caffeic acid. In a cytotoxicity assay, we measured the number of C2C12 cells after a 24 h incubation in a differentiation medium supplemented with the test substances (final concentrations: 1, 10, and 100 μM). As shown in Table 3, little significant change was observed in the viable cell rate (% of the control) in the presence of compounds 15, quercetin, kaempferol, sinapic acid, ferulic acid, and caffeic acid at 1–100 µM, except for a significant decrease (23.4%, and 33.4%, respectively), which was noted for 100 µM quercetin and kaempferol.
As described in the “Materials and Methods” section, cultured C2C12 cells were treated with a differentiation medium containing the test compounds (1, 10, and 100 µM) in the presence or absence of insulin for 1 h, and glucose uptake levels in cells were measured. In comparison with the control, glucose uptake levels significantly increased in the absence of insulin when cells were cultured with compounds 1 (22.2–28.4%), 2 (30.9% at 1 µM), 3 (20.1–30.7%), 4 (27.4–45.5%), and 5 (14.9–16.8%) as well as with kaempferol (35.0–44.5%), sinapic acid (27.3–35.8%), and ferulic acid (16.2–20.5%), at 1, 10, and 100 µM (Table 4). A significant decrease was observed with compound 2, quercetin, and kaempferol at 100 µM. Caffeic acid did not significantly affect glucose uptake. Furthermore, glucose uptake in the presence of insulin was significantly increased by compounds 3 (1 µM) and 4 (100 µM), kaempferol (1, 10 µM), and sinapic acid (1–100 µM) (Table 5). A significant decrease in glucose uptake was noted with compounds 3 (100 µM), 4 (1 µM), and 5 (100 µM), quercetin (1–100 µM), and kaempferol (100 µM). Ferulic acid and caffeic acid did not significantly affect glucose uptake.

4. Discussion

In the present study, a Petit vert extract was prepared by extracting its dried and powdered outer leaves with MeOH. The extract was subsequently analyzed by HPLC. We identified several peaks that appeared to correspond to polyphenols with absorption at approximately UV 330 nm. The dried and powdered outer leaves of Petit vert were extracted, fractionated, and purified to isolate five compounds (compounds 15). NMR spectroscopy was performed for each of the components to elucidate their structures. Compounds 25 isolated from Petit vert leaves were glycosides that contained either kaempferol or quercetin with a sinapoyl group. Compound 1 was previously isolated from broccoli florets [11], compounds 2, 3, and 5 from kale leaves [12], and compounds 4 and 5 from cabbage leaves [14,15]. Compounds 15 all contained sinapic acid, which is an acyl group. According to the HPLC analysis of Petit vert leaves and side shoots, compounds 25 with flavonols were more abundant in the leaves than in the side shoots, while compound 1 containing only sinapic acid, was more abundant in the side shoots.
We investigated the effects of the following ten compounds on glucose uptake in cultured C2C12 murine myoblasts: five compounds were isolated from the outer leaves of Petit vert (compounds 15), quercetin, kaempferol, and related acyl groups, including sinapic acid, ferulic acid, and caffeic acid. Glucose uptake in cultured C2C12 murine myoblasts in the absence of insulin was significantly increased by compounds 15, kaempferol, sinapic acid, and ferulic acid (Table 4), while uptake in the presence of insulin was also significantly increased by compounds 3 and 4, kaempferol, and sinapic acid (Table 5). The significant decrease detected in glucose uptake at higher concentrations of quercetin and kaempferol may have been due to a reduction in the viable cell rate (Table 3). The five compounds isolated from the outer leaves of petit vert, as well as quercetin, kaempferol, and sinapic acid, increased glucose uptake in cultured C2C12 murine myoblasts. These results indicate that the biological activities of the outer leaves of Petit vert, such as increases in glucose uptake, were the summed effects of the phenolic compounds present.
Phenolic acids and their derivatives compose one of the most common groups of phenolic compounds in plants. These molecules have emerged as high-value-added products because of their essential role in human nutrition and health [16,17]. Previous studies reported the effects of phenolic compounds, such as sinapic acid, related to those isolated from Petit vert leaves. For example, kaempferol was shown to exert anti-obesity effects because it increased insulin secretion in beta cells [18]. Sinapic acid has attracted increasing attention due to its numerous pharmacological effects [19]. It has been shown to exhibit antihyperglycemic [20], antioxidant [21], anti-inflammatory [22], anti-cancer [23], hepatoprotective [24], cardioprotective [25], renoprotective [26], neuroprotective [9], anti-diabetic [27], and anti-bacterial activities [28]. The compounds identified from the leaves of the Petit vert vegetable in the present study contain interesting compounds, such as sinapic acid, which have been previously reported to have ameliorative effects on various diseases at the preclinical level. Therefore, it is assumed that the consumption of this vegetable can contribute to human health in the future.

5. Conclusions

The present study reports for the first time the isolation of five compounds containing sinapic acid from the outer leaves of Petit vert and their stimulation of glucose uptake in cultured C2C12 murine myoblasts. The results obtained herein suggest the potential of these compounds to effectively attenuate hyperglycemia and maintain muscle strength by promoting glucose metabolism in muscle cells. It is expected that the present study may become a trigger for the further elucidation of health benefits of Petit vert vegetables.

Supplementary Materials

The following supporting information can be downloaded at https://www.mdpi.com/article/10.3390/biom14101246/s1. Chart S1: 1H and 13C NMR spectra of compounds 14 and 5.

Author Contributions

S.Y.: Writing—original draft, Supervision, Investigation. T.W.: Investigation, Data curation, Formal analysis. O.S.: Investigation, Data curation, Formal analysis. Y.K.: Writing draft, Formal analysis. T.F.: Investigation, Writing—review and editing, Supervision, Funding acquisition, Conceptualization. All authors have read and agreed to the published version of the manuscript.

Funding

The research received no external funding.

Data Availability Statement

The data presented in this study are available from the corresponding author upon reasonable request.

Conflicts of Interest

The authors declare no competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

References

  1. Ou, S.; Kwok, K.C. Ferulic acid: Pharmaceutical functions, preparation and applications in foods. J. Sci. Food Agric. 2004, 84, 1261–1269. [Google Scholar] [CrossRef]
  2. Fresco, P.; Borges, F.; Diniz, C.; Marques, M. New insights on the anticancer properties of dietary polyphenols. Med. Res. Rev. 2006, 26, 747–766. [Google Scholar] [CrossRef] [PubMed]
  3. Darvesh, A.S.; Carroll, R.T.; Bishayee, A.; Geldenhuys, W.J.; Van der Schyf, C.J. Oxidative stress and Alzheimer’s diseases: Dietary polyphenols as potential therapeutic agents. Expert Rev. Neurother. 2010, 10, 729–745. [Google Scholar] [CrossRef]
  4. Niciforovic, N.; Abramovic, H. Sinapic acid and its derivatives: Natural sources and bioactivity. Compr. Rev. Food Sci. Food Saf. 2014, 13, 34–51. [Google Scholar] [CrossRef]
  5. Karakida, F.; Ikeya, Y.; Tsunakawa, M.; Yamaguchi, T.; Ikarashi, Y.; Takeda, S.; Aburada, M. Cerebral protective and cognition-improving effects of sinapic acid in rodents. Biol. Pharm. Bull. 2007, 30, 514–519. [Google Scholar] [CrossRef] [PubMed]
  6. Lee, I.-S.; Choi, G.-Y.; Sreelatha, I.; Yoon, J.-W.; Youn, S.-H.; Maeng, S.; Park, J.-H. Effect of sinapic acid on scopolamine-induced learning and memory impairment in SD rats. Brain Sci. 2023, 13, 427. [Google Scholar] [CrossRef]
  7. Lee, H.E.; Kim, D.H.; Park, S.J.; Kim, J.M.; Lee, Y.W.; Jung, J.M.; Lee, C.H.; Hong, J.G.; Liu, X.; Cai, M.; et al. Neuroprotective effect of sinapic acid in a mouse model of amyloid b1-42 protein-induced Alzheimer’s disease. Pharmacol. Biochem. Behav. 2012, 103, 260–266. [Google Scholar] [CrossRef]
  8. Verma, V.; Singh, D.; Kh, R. Sinapic acid alleviates oxidative stress and neuro- inflammatory changes in sporadic model of Alzheimer’s disease in rats. Brain Sci. 2020, 10, 923. [Google Scholar] [CrossRef]
  9. Zare, K.; Eidi, A.; Roghani, J.; Rohani, A.H. The neuroprotective potential of sinapic acid in the 6-hydroxydopamine-induced hemi-parkinsonian rat. Metab. Brain Dis. 2015, 30, 205–213. [Google Scholar] [CrossRef]
  10. Nishida, H.; Kuriyama, Y.; Kawakami, K.; Takei, Y.; Chiba, T.; Masuda, H.; Kazama, K.; Ohtsuka, A.; Sato, S.; Konishi, T. Anti-obesitic effect of petit vert on mice fed a high-fat diet. J. Jpn. Soc. Nutr. Food Sci. 2011, 64, 169–175. (in Japanese). [Google Scholar] [CrossRef]
  11. Price, K.R.; Casuscelli, F.; Colquhoun, I.J.; Rhodes, M.J.C. Hydroxycinnamic acid esters from broccoli florets. Phytochemistry 1997, 45, 1683–1687. [Google Scholar] [CrossRef]
  12. Fiol, M.; Adermann, S.; Neugart, S.; Rohn, S.; Mügge, C.; Schreiner, M.; Krumberin, A.; Kroh, L.W. Highly glycosylated and acylated flavonols from kale (Brassica oleracea var. sabellica)—Structure-antioxidant activity relationship. Food Res. Int. 2012, 47, 80–89. [Google Scholar] [CrossRef]
  13. Olsson, L.C.; Veit, M.; Weissenböck, G.; Bornman, J.F. Differential flavonoid response to enhanced UV-B radiation in Brassica napus. Phytochemistry 1998, 49, 1021–1028. [Google Scholar] [CrossRef]
  14. Nielsen, J.K.; Olesen, C.E.L.; Petersen, M.K. Acylated flavonol glycosides from cabbage leaves. Phytochemistry 1993, 34, 539–544. [Google Scholar] [CrossRef]
  15. Nielsen, J.K.; Nørbæk, R.; Olsen, C.E. Kaempferol tetraglucosides from Cabbage leaves. Phytochemistry 1998, 49, 2171–2176. [Google Scholar] [CrossRef] [PubMed]
  16. Ranilla, L.G.; Kwon, Y.-I.; Apostolidis, E.; Shetty, K. Phenolic compounds, antioxidant activity and in vitro inhibitory potential against key enzymes relevant for hyperglycemia and hypertension of commonly used medicinal plants, herbs and spices in Latin America. Bioresour. Technol. 2010, 101, 4676–4689. [Google Scholar] [CrossRef]
  17. Cory, H.; Passarellim, S.; Szeto, J.; Tamez, M.; Mattei, J. The role of polyphenols in human health and food systems: A mini-review. Front. Nutr. 2018, 5. [Google Scholar] [CrossRef] [PubMed]
  18. Zhang, Y.; Liu, D. Flavonol kaempferol improves chronic hyperglycemia-impaired pancreatic beta-cell viability and insulin secretory function. Eur. J. Pharmacol. 2011, 670, 325–332. [Google Scholar] [CrossRef] [PubMed]
  19. Pandi, A.; Kalappan, V.M. Pharmacological and therapeutic applications of sinaptic acid-an updated review. Mol. Biol. Reports. 2021, 48, 3733–3745. [Google Scholar] [CrossRef]
  20. Cherng, Y.G.; Tsai, C.C.; Chung, H.H.; Lai, Y.W.; Kuo, S.C.; Cheng, J.T. Antihyperglycemic action of sinapic acid in diabetic rats. J. Agric. Food Chem. 2013, 61, 12053–12059. [Google Scholar] [CrossRef]
  21. Dubie, J.; Stancik, A.; Morra, M.; Nindo, C. Antioxidant extraction from mustard (Brassica juncea) seed meal using high-intensity ultrasound. J. Food Sci. 2013, 78, E542–E548. [Google Scholar] [CrossRef] [PubMed]
  22. Li, X.; Lin, J.; Ding, X.; Xuan, J.; Hu, Z.; Wu, D.; Zhu, X.; Feng, Z.; Ni, W.; Wu, A. The protective effect of sinapic acid in osteoarthritis: In vitro and in vivo studies. J. Cell. Mol. Med. 2019, 23, 1940–1950. [Google Scholar] [CrossRef] [PubMed]
  23. Balaji, D.; Muthukumaran, J.; Nalini, N. Chemopreventive effect of sinapic acid on 1,2-dimethylhydrazine-induced experimental rat colon carcinogenesis. Hum.Exp. Toxicol. 2014, 33, 1253–1268. [Google Scholar] [CrossRef] [PubMed]
  24. Shin, D.S.; Kim, K.W.; Chung, H.Y.; Yoon, S.; Moon, J.O. Effect of sinapic acid against carbon tetrachloride-induced acute hepatic injury in rats. Arch. Pharm. Res. 2013, 36, 626–633. [Google Scholar] [CrossRef]
  25. Roy, S.J.; Mainzen Prince, P.S. Protective effects of sinapic acid on cardiac hypertrophy, dyslipidaemia and altered electrocardiogram in isoproterenol-induced myocardial infarcted rats. Eur. J. Pharmacol. 2013, 699, 213–218. [Google Scholar] [CrossRef]
  26. Ansari, M.A.; Raish, M.; Ahmad, A.; Alkharfy, K.M.; Ahmad, S.F.; Attia, S.M.; Alsaad, A.M.S.; Bakheel, S.A. Sinapic acid ameliorate cadmiun-induced nephrotoxicity: In vivo possible involvement of oxidative stress, apoptosis, and inflammation via NF-kaB NF-κB downregulation. Environ. Toxicol. Pharmacol. 2017, 51, 100–107. [Google Scholar] [CrossRef]
  27. Kanchana, G.; Shyni, W.J.; Rajadurai, M.; Periasamy, R. Evaluation of anti-hyperglycemic effect of sinapic acid in normal and streptozocin (STZ)-induced diabetic diabetes in albino rats. Global J. Pharmacol. 2011, 5, 33–39. [Google Scholar]
  28. Tesaki, S.; Tanabe, S.; Ono, H.; Fukushi, E.; Kawabata, J.; Watanabe, M. 4-Hydroky-3-nitrophenylacetic and sinapic acid as antibacterial compounds from Mustard seed. Biosci. Biotechnol. Biochem. 1998, 62, 998–1000. [Google Scholar] [CrossRef]
Figure 1. Petit vert (scientific name: Brassica oleracea var. gemmifera DC. × Brassica oleracea var. acephala DC.). (1) Petit vert. (2) Side shoots. (3) Leaf.
Figure 1. Petit vert (scientific name: Brassica oleracea var. gemmifera DC. × Brassica oleracea var. acephala DC.). (1) Petit vert. (2) Side shoots. (3) Leaf.
Biomolecules 14 01246 g001
Figure 2. Observed key 1H-1H COSY, HMBC, and ROE correlations of compound 2.
Figure 2. Observed key 1H-1H COSY, HMBC, and ROE correlations of compound 2.
Biomolecules 14 01246 g002
Figure 3. Structures of compounds 110.
Figure 3. Structures of compounds 110.
Biomolecules 14 01246 g003
Figure 4. HPLC profiles of MeOH extracts from Petit vert leaf (a) and Petit vert side shoots (b). HPLC conditions [column: Cosmosil 2.5Cholester (2.5 µm), i.d. 3.0 × 100 mm (NACALAI TESQUE, INC.); mobile phase: A 0.1%TFA in water, B CH3CN, gradient, 0–20 min: 6–11% B linear, 20–36 min: 11–27% B linear, 36–45 min: 27% B; and flow rate: 0.75 mL/min; Detection: UV 330 nm; [Column temperature: 40 ℃].
Figure 4. HPLC profiles of MeOH extracts from Petit vert leaf (a) and Petit vert side shoots (b). HPLC conditions [column: Cosmosil 2.5Cholester (2.5 µm), i.d. 3.0 × 100 mm (NACALAI TESQUE, INC.); mobile phase: A 0.1%TFA in water, B CH3CN, gradient, 0–20 min: 6–11% B linear, 20–36 min: 11–27% B linear, 36–45 min: 27% B; and flow rate: 0.75 mL/min; Detection: UV 330 nm; [Column temperature: 40 ℃].
Biomolecules 14 01246 g004
Table 1. 13C NMR spectroscopic data of flavonoid glycosides and a cinnamic acid derivative (δ/ppm; 175 or 125 MHz instruments).
Table 1. 13C NMR spectroscopic data of flavonoid glycosides and a cinnamic acid derivative (δ/ppm; 175 or 125 MHz instruments).
Compound 1 a2 b3 b4 b5 b
Aglycone moiety
C-2157.5 157.3157.7157.5
3135.0 134.9134.8134.8
4179.1 179.1179.1179.4
5162.2 162.1162.1162.2
6100.6 100.6100.7100.7
7164.1 164.2164.1164.2
895.4 95.195.395.3
9157.3 157.5157.3157.4
10107.5 107.4107.5107.5
1′123.3 123.3122.9123.0
2′117.2 117.1132.2132.2
3′149.8 149.7116.2116.1
4′145.9 145.9161.4161.5
5′116.1 116.1116.2116.1
6′123.3123.3132.2132.2
Suger moiety
(3)-O-sugars
C-191.9 96.9 96.997.0 97.0
273.582.082.082.082.1
373.875.175.175.175.1
470.0 71.471.371.571.5
576.7 78.3 78.378.278.3
667.8 62.2 62.262.262.3
C-1′103.1 98.498.498.598.5
2′72.6 75.075.075.075.0
3′76.575.875.875.875.9
4′70.0 71.2 71.171.271.2
5′76.877.877.877.877.9
6′61.062.262.262.262.2
7-O-sugars
C-1″101.2 101.4101.2 101.5
2″74.574.874.574.8
3″76.077.776.077.7
4″80.171.480.271.4
5″76.678.176.678.2
6″61.662.561.762.5
C-1‴104.5104.5
2‴74.974.9
3‴77.877.8
4‴71.371.3
5‴78.178.0
6‴62.462.4
Ester moiety
C-α164.9168.6 168.6168.4168.4
β113.5115.9 115.9116.0116.0
γ145.8146.6 146.6146.5146.5
1124.3 125.9125.9126.0126.0
2106.3 105.5 105.5105.6105.6
3148.0 148.7 148.7148.7148.8
4138.4 138.7 138.7138.7138.8
5148.0 148.7 148.7148.7148.8
6106.3105.5 105.5105.6105.6
OMe56.1 × 2 56.2 × 2 56.2 × 256.3 × 2 56.3 × 2
C-α165.6
β114.6
γ147.3
1′124.0
2′106.6
3′148.0
4′138.9
5′148.0
6′106.6
OMe56.1 × 2
a: Measured in DMSO-d6. b: Measured in MeOH-d4.
Table 2. 1H NMR spectroscopic data of flavonoid glycosides and a cinnamic acid derivative (δ/ppm; 700 or 500 MHz instruments).
Table 2. 1H NMR spectroscopic data of flavonoid glycosides and a cinnamic acid derivative (δ/ppm; 700 or 500 MHz instruments).
Compound 1 a2 b3 b4 b5 b
Aglycone moiety
H-66.37 (d, 2.0)6.37 (d, 2.0)6.38 (s)6.38 (d, 2.0)
86.34 (d, 2.0)6.36 (d, 2.0)6.38 (s)6.40 (d, 2.0)
2′7.50 (d, 2.0)7.51 (d, 2.0)7.89 (d, 8.5)7.90 (d, 8.5)
3′6.90 (d, 8.5)6.90 (d, 8.5)
5′6.88 (d, 8.5)6.88 (d, 8.5)6.90 (d, 8.5)6.90 (d, 8.5)
6′7.45 (dd, 8.5, 2.0)7.46 (dd, 8.5, 2.0)7.89 (d, 8.5)7.90 (d, 8.5)
Sugar moiety
(3)-O-Sugar
H-15.77 (d, 8.0)6.18 (d, 8.0)6.19 (d, 8.0)6.16 (d, 8.0)6.17 (d, 8.0)
24.91 (dd 8.5, 8.0)3.58 *3.58 *3.53 *3.52 *
33.59 *3.84 (t, 9.0)3.85 (t, 9.0)3.85 (t, 9.0)3.84 (t, 9.0)
43.39 (t, 9.0)3.34 (t, 9.0)3.34 (t, 9.0)3.32 (t, 9.0)3.31 *
53.59 *3.27 (m)3.27 (m)3.29 *3.27 (m)
64.05 (brd, 9.5)3.67 (dd, 12.0, 2.5)3.67 (dd, 12.0, 2.0)3.67 (brd, 12.0)3.67 (dd, 12.0, 2.0)
63.67 *3.51 (dd, 12.0, 5.5)3.51 *3.50 (dd, 12.0, 5.5)3.49 (dd, 12.0, 5.5)
1′4.20 (d, 8.0)5.24 (d, 8.0)5.25 (d, 8.0)5.25 (d, 8.0)5.24 (d, 8.0)
2′2.99 (dd, 9.0, 8.0)4.93 (dd, 9.0, 8.0)4.93 (dd, 9.0, 8.0)4.95 (dd, 9.0, 8.0)4.94 (dd, 9.0, 8.0)
3′3.14 (t, 9.0)3.80 (t, 9.0)3.80 (t, 9.0)3.81 (t, 9.0)3.79 (t, 9.0)
4′3.08 *3.53 *3.54 *3.53 *3.52 *
5′3.08 *3.53 *3.52 *3.53 *3.52 *
6′3.67 * 3.93 (brd, 12.0)3.93 (brd, 12.0) 3.91 *3.93 (dd, 12.0, 2.0)
6′3.45 *3.78 (dd, 12.0, 4.0)3.78 (dd, 12.0, 4.0)3.78 (dd, 12.0, 4.0)3.77 (dd, 12.0, 5.5)
7-O-Sugar
H-1″5.13 (d, 8.0)5.10 (d, 8.0)5.13 (d, 8.0)5.10 (d, 8.0)
2″3.57 (dd, 9.0, 8.0)3.51 *3.58 (dd, 9.0, 8.0)3.50 *
3″3.75 (t, 9.0)3.58 *3.75 (t, 9.0)3.58 *
4″3.69 (t, 9.0)3.42 (t, 9.0)3.69 (t, 9.0)3.41 (t, 9.0)
5″3.72 *3.57 *3.72 *3.57 *
6″3.98 (dd, 12.0, 2.2)3.95 (dd, 12.0, 2.5)3.99 (brd, 12.0)3.94 (dd, 12.0, 2.0)
6″3.93 (brd, 12.0)3.74 (dd, 12.0, 6.0)3.91 *3.73 (dd, 12.0, 6.0)
H-1 4.48 (d, 8.0)4.48 (d, 8.0)
2‴3.29 (dd, 9.0, 8.0)3.30 *
3‴3.42 (t, 9.0)3.43 (t, 9.0)
4‴3.34 (t, 9.0)3.35 (t, 9.0)
5‴3.39 *3.40 *
6‴3.92 (dd, 12.0, 2.5)3.91 *
6‴3.70 *3.70 *
Ester moiety
H-β6.49 (d, 16.0)6.09 (d, 16.0)6.09 (d, 16.0)6.10 (d, 16.0)6.10 (d, 16.0)
γ7.55 (d, 16.0)7.30 (d, 16.0)7.30 (d, 16.0)7.31 (d, 16.0)7.31 (d, 16.0)
2,66.99 (s)6.23 (s)6.23 (s)6.25 (s)6.25 (s)
OMe3.77 (s)× 23.59 (s ) × 23.59 (s) × 23.59 (s) × 23.60 (s) × 2
H-β6.44 (d, 16.0)
γ7.53 (d, 16.0)
2′,6′6.96 (s)
OMe′3.78 (s) × 2
a: Measured in DMSO-d6. b: Measured in MeOH-d4. *: Overlapping with other signals.
Table 3. Effect of various compounds in the cytotoxicity assay.
Table 3. Effect of various compounds in the cytotoxicity assay.
Test SubstanceControl110100
(µM)
Viable Cell Rate (% of Control)
1100.0 ± 0.9105.0 ± 1.6101.4 ± 1.1103.1 ± 0.7
2100.0 ± 0.696.0 ± 0.994.9 ± 1.196.1 ± 1.0
3100.0 ± 0.997.9 ± 0.498.9 ± 1.1103.8 ± 1.1
4100.0 ± 1.188.6 ± 0.893.5 ± 1.891.6 ± 0.7
5100.0 ± 0.298.5 ± 2.5102.0 ± 1.199.5 ± 0.8
Quercetin (6)100.0 ± 0.6102.0 ± 0.498.0 ± 1.176.6 ± 1.2 *
Kaempferol (7)100.0 ± 1.2105.7 ± 2.5111.1 ± 1.766.6 ± 1.0 *
Sinapic acid (8)100.0 ± 1.4110.0 ± 1.4107.0 ± 0.9119.1 ± 2.4
Ferulic acid (9)100.0 ± 0.6102.4 ± 1.2108.4 ± 1.3111.5 ± 0.3
Caffeic acid (10)100.0 ± 0.1107.0 ± 1.7107.8 ± 1.6101.0 ± 2.4
Each value represents the mean ± S.E. for 3 determinations. * p < 0.05, significantly different from the control (0.1% DMSO).
Table 4. Effects of various compounds on glucose uptake by C2C12 skeletal muscle cells in the absence of insulin.
Table 4. Effects of various compounds on glucose uptake by C2C12 skeletal muscle cells in the absence of insulin.
Test CompoundsControl110100
(µM)
Uptake (% of Control)
1100.0 ± 2.8128.4 ± 5.5 **125.2 ± 3.2 ***122.1 ± 1.4 ***
2100.0 ± 2.8130.9 ± 8.0 *108.7 ± 4.888.3 ± 1.8 *
3100.0 ± 3.6130.7 ± 6.9 **120.1 ± 1.9 **100.8 ± 3.7
4100.0 ± 3.6110.4 ± 5.6127.4 ± 5.0 **145.5 ± 2.8 ***
5100.0 ± 3.7116.8 ± 3.5*114.9 ± 2.5 *103.0 ± 4.7
Quercetin (6)100.0 ± 3.7104.1 ± 3.5102.3 ± 2.825.5 ± 0.7 ***
Kaempferol (7)100.0 ± 4.4135.0 ± 2.4 ***144.5 ± 9.5 **39.8 ± 1.4 ***
Sinapic acid (8)100.0 ± 4.4135.8 ± 6.8 **129.7 ± 4.9 **127.3 ± 3.7 **
Ferulic acid (9)100.0 ± 3.7105.6 ± 2.4120.5 ± 2.8 **116.2 ± 1.5 **
Caffeic acid (10)100.0 ± 3.7129.9 ± 11.7111.9 ± 5.0108.6 ± 7.1
After treatment with various compounds at the indicated concentration in the absence of insulin, glucose uptake was measured using the Promega Glucose Uptake-Glo™ Assay kit. Each value represents the mean ± S.E. for 5 determinations. *** p < 0.001, ** p < 0.01, * p < 0.05 represent significant differences from the control (0.1% DMSO).
Table 5. Effects of various compounds on glucose uptake by C2C12 skeletal muscle cells in the presence of insulin.
Table 5. Effects of various compounds on glucose uptake by C2C12 skeletal muscle cells in the presence of insulin.
Test CompoundsControl110100
(µM)
Uptake (% of Control)
1100.0 ± 8.496.3 ± 4.092.1 ± 2.981.8 ± 1.8
2100.0 ± 8.484.4 ± 1.982.2 ± 3.983.8 ± 5.2
3100.0 ± 3.1110.6 ± 2.6 *120.5 ± 7.481.9 ± 4.6 *
4100.0 ± 3.174.2 ± 2.9 ***90.5 ± 1.7123.1 ± 9.4 *
5100.0 ± 3.5114.5 ± 5.4103.7 ± 5.781.1 ± 4.4 *
Quercetin (6)100.0 ± 3.572.9 ± 5.5 **76.8 ± 3.7 **20.1 ± 1.8 ***
Kaempferol (7)100.0 ± 4.6148.4 ± 6.8 ***132.7 ± 2.3 ***31.7 ± 1.0 ***
Sinapic acid (8)100.0 ± 4.6116.5 ± 1.5 *119.3 ± 2.7 *123.0 ± 3.1 **
Ferulic acid (9)100.0 ± 8.697.0 ± 2.0118.7 ± 7.394.9 ± 2.2
Caffeic acid (10)100.0 ± 8.694.3 ± 1.9101.7 ± 5.699.5 ± 0.7
After treatment with various compounds at the indicated concentration in the presence of insulin, glucose uptake was measured using the Promega Glucose Uptake-Glo™ Assay kit. Each value represents the mean ± S.E. for 5 determinations. *** p < 0.001, ** p < 0.01, * p < 0.05 represent significant differences from the control (0.1% DMSO).
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Yamada, S.; Warashina, T.; Shirota, O.; Kato, Y.; Fukuda, T. Identification of Sinapic Acid Derivatives from Petit Vert Leaves and Their Effects on Glucose Uptake in C2C12 Murine Myoblasts. Biomolecules 2024, 14, 1246. https://doi.org/10.3390/biom14101246

AMA Style

Yamada S, Warashina T, Shirota O, Kato Y, Fukuda T. Identification of Sinapic Acid Derivatives from Petit Vert Leaves and Their Effects on Glucose Uptake in C2C12 Murine Myoblasts. Biomolecules. 2024; 14(10):1246. https://doi.org/10.3390/biom14101246

Chicago/Turabian Style

Yamada, Shizuo, Tsutomu Warashina, Osamu Shirota, Yoshihisa Kato, and Toshiyuki Fukuda. 2024. "Identification of Sinapic Acid Derivatives from Petit Vert Leaves and Their Effects on Glucose Uptake in C2C12 Murine Myoblasts" Biomolecules 14, no. 10: 1246. https://doi.org/10.3390/biom14101246

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Article metric data becomes available approximately 24 hours after publication online.
Back to TopTop